$3.00
-0.23-6.97%
At close: -
$3.07
0.062.16%
After Hours: 4:37 PM EDT
Comments
Loading...
Arbutus Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:ABUS | Benzinga
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.120
Quarterly Revenue Estimate
$1.97M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$6.17M
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma | -$0.10 | -$0.12 | — | — | $1.53M | $1.97M | — | — | 05/01/2025 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.12 | -$0.12 | -$0.07 | 41.67% | $2.15M | $2.21M | $1.57M | -28.78% | 03/27/2025 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.12 | -$0.09 | -$0.10 | -11.11% | $4.66M | $1.86M | $1.34M | -28.01% | 11/06/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.10 | -$0.11 | -10.00% | $4.65M | $1.75M | $1.73M | -1.37% | 08/01/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.11 | -$0.10 | 9.09% | $6.69M | $2.15M | $1.53M | -28.74% | 05/02/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.14 | -$0.12 | -$0.12 | 0.00% | $6.25M | $4.79M | $2.15M | -55.22% | 02/29/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.12 | -$0.11 | -$0.12 | -9.09% | $5.95M | $4.75M | $4.66M | -1.94% | 11/07/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.12 | -$0.10 | 16.67% | $14.24M | $5.02M | $4.65M | -7.35% | 08/03/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.11 | -$0.14 | -$0.10 | 28.57% | $12.58M | $6.03M | $6.69M | 10.90% | 05/04/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.15 | -$0.13 | -$0.14 | -7.69% | $3.21M | $6.17M | $6.25M | 1.22% | 03/02/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.24 | -$0.13 | -$0.12 | 7.69% | $3.34M | $9.37M | $5.95M | -36.48% | 11/09/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.23 | -$0.13 | -$0.10 | 23.08% | $2.33M | $6.77M | $14.24M | 110.35% | 08/04/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.21 | -$0.16 | -$0.11 | 31.25% | $2.11M | $4.37M | $12.58M | 187.89% | 05/05/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.23 | -$0.19 | -$0.15 | 21.05% | $2.39M | $2.87M | $3.21M | 11.71% | 03/03/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.27 | -$0.24 | -$0.24 | 0.00% | $1.52M | $2.38M | $3.34M | 40.34% | 11/04/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.25 | -$0.22 | -$0.23 | -4.55% | $1.51M | $2.12M | $2.33M | 9.86% | 08/05/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.25 | -$0.23 | -$0.21 | 8.70% | $1.49M | $3.31M | $2.11M | -36.16% | 05/05/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.46 | -$0.22 | -$0.23 | -4.55% | $1.62M | $1.96M | $2.39M | 21.73% | 03/04/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.73 | -$0.22 | -$0.27 | -22.73% | $3.10M | $1.66M | $1.52M | -8.25% | 11/05/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.46 | -$0.24 | -$0.25 | -4.17% | $700.00K | $1.74M | $1.51M | -12.99% | 08/07/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.47 | -$0.39 | -$0.25 | 35.90% | $700.00K | $220.00K | $1.49M | 577.73% | 05/11/2020 | Get Alert |
Arbutus Biopharma (ABUS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-0.07 | $-0.12 | 41.7 % |
| Q3 | 2024-11-06 | $-0.10 | $-0.09 | -11.1 % |
| Q2 | 2024-08-01 | $-0.11 | $-0.10 | -10.0 % |
| Q1 | 2024-05-02 | $-0.10 | $-0.11 | 9.09 % |
Arbutus Biopharma (ABUS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $1.57M | $2.21M | -28.8 % |
| Q3 | 2024-11-06 | $1.34M | $1.86M | -28.0 % |
| Q2 | 2024-08-01 | $1.73M | $1.75M | -1.37 % |
| Q1 | 2024-05-02 | $1.53M | $2.15M | -28.7 % |
FAQ
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma (ABUS) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Arbutus Biopharma (NASDAQ:ABUS)?
The Actual EPS was $-0.07, which beat the estimate of $-0.12.
What were Arbutus Biopharma’s (NASDAQ:ABUS) revenues?
The Actual Revenue was $1.6M, which missed the estimate of $2.2M.
Browse earnings estimates, EPS, and revenue on all stocks.